SEC Focus on the Life Sciences Industry

With any administration change will come new regulatory considerations across the life sciences industry. Join Morgan Lewis partners and former US Securities and Exchange Commission (SEC) staff Kelly Gibson and Carolyn Welshhans as they share some of their institutional knowledge as relates to the workings and priorities of the SEC for 2025.

Topics will include:

• Disclosure issues
• Insider trading
• Cybersecurity concerns
• Proactive steps to head off SEC interest
• What to do if the SEC does reach out